Kartogenin(CAS: 4727-31-5)

Kartogenin (CAS: 4727-31-5) is regulated under various guidelines including the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH in the European Union, and FDA regulations for use in pharmaceuticals and cosmetics. It is recommended that manufacturers and users comply with local and international standards for handling and storage.

Alternatives to Kartogenin (CAS: 4727-31-5) in synthesis include other small molecule inhibitors with similar biological activities. For instance, isoform-specific modulators or structurally related compounds can be used as substitutes. Researchers often explore these alternatives to optimize biological effects or reduce potential side effects.

The market for Kartogenin (CAS: 4727-31-5) is growing due to its applications in cancer research and cell biology. Research trends focus on exploring its potential as a therapeutic agent and understanding its mechanisms of action. Increasing interest in its use for drug discovery is driving market expansion.

Waste containing Kartogenin (CAS: 4727-31-5) should be collected in appropriate containers, labeled clearly, and disposed of through professional waste disposal services. Environmental protection precautions include ensuring no leakage and proper handling to prevent contamination. Compliance with local hazardous waste regulations is essential.